Bionano Genomics, Inc. Quarterly Operating Income (Loss) in USD from Q3 2017 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: The net result for the period of deducting operating expenses from operating revenues.
Summary: Bionano Genomics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2017 to Q3 2024.
Bionano Genomics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$43.9M, a 61.2% increase year-over-year.
Bionano Genomics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$117M, a 48.6% increase year-over-year.
Bionano Genomics, Inc. annual Operating Income (Loss) for 2023 was -$215M, a 63.4% decline from 2022.
Bionano Genomics, Inc. annual Operating Income (Loss) for 2022 was -$132M, a 70.8% decline from 2021.
Bionano Genomics, Inc. annual Operating Income (Loss) for 2021 was -$77.1M, a 100% decline from 2020.

Operating Income (Loss), Trailing 12 Months (USD)

Operating Income (Loss), Quarterly (USD)

Operating Income (Loss), YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q3 2024	-$117M	-$43.9M	+$69.3M	+61.2%	Jul 1, 2024	Sep 30, 2024	10-Q	2024-11-14
Q2 2024	-$186M	-$17M	+$22.2M	+56.6%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-07
Q1 2024	-$209M	-$31.1M	+$6.72M	+17.8%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-08
Q4 2023	-$215M	-$25M	+$12.6M	+33.5%	Oct 1, 2023	Dec 31, 2023	10-K	2024-03-05
Q3 2023	-$228M	-$113M	-$81.1M	-252%	Jul 1, 2023	Sep 30, 2023	10-Q	2024-11-14
Q2 2023	-$147M	-$39.2M	-$7.16M	-22.3%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-07
Q1 2023	-$140M	-$37.8M	-$7.9M	-26.4%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-08
Q4 2022	-$132M	-$37.5M	-$8.74M	-30.4%	Oct 1, 2022	Dec 31, 2022	10-K	2024-03-05
Q3 2022	-$123M	-$32.1M	-$11.5M	-55.5%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-08
Q2 2022	-$111M	-$32.1M	-$15.6M	-94.7%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-09
Q1 2022	-$95.9M	-$29.9M	-$18.8M	-168%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-09
Q4 2021	-$77.1M	-$28.8M	-$17.7M	-159%	Oct 1, 2021	Dec 31, 2021	10-K	2023-03-09
Q3 2021	-$59.4M	-$20.7M	-$10.5M	-102%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-03
Q2 2021	-$49M	-$16.5M	-$9.04M	-122%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-04
Q1 2021	-$40M	-$11.2M	-$1.4M	-14.4%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-05
Q4 2020	-$38.6M	-$11.1M	-$3.97M	-55.4%	Oct 1, 2020	Dec 31, 2020	10-K	2022-03-01
Q3 2020	-$34.6M	-$10.2M	-$4.54M	-79.9%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-04
Q2 2020	-$30M	-$7.44M	-$591K	-8.64%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-04
Q1 2020	-$29.5M	-$9.76M	-$3.58M	-57.8%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-13
Q4 2019	-$25.9M	-$7.16M	-$1.06M	-17.4%	Oct 1, 2019	Dec 31, 2019	10-K	2021-03-23
Q3 2019	-$24.8M	-$5.69M	+$284K	+4.76%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-13
Q2 2019	-$25.1M	-$6.84M	-$2.83M	-70.6%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-08-13
Q1 2019	-$22.3M	-$6.19M	-$1.85M	-42.7%	Jan 1, 2019	Mar 31, 2019	10-Q	2020-06-18
Q4 2018	-$20.4M	-$6.1M			Oct 1, 2018	Dec 31, 2018	10-K	2020-03-10
Q3 2018		-$5.97M	-$938K	-18.6%	Jul 1, 2018	Sep 30, 2018	10-Q	2019-11-07
Q2 2018		-$4.01M			Apr 1, 2018	Jun 30, 2018	10-Q	2019-08-08
Q1 2018		-$4.34M			Jan 1, 2018	Mar 31, 2018	10-Q	2019-05-09
Q3 2017		-$5.03M			Jul 1, 2017	Sep 30, 2017	10-Q	2018-11-07

* An asterisk sign (*) next to the value indicates that the value is likely invalid.